Synthesis of novel thiazolidinic-phthalimide derivatives evaluated as new multi-target antiepileptic agents

[Display omitted] •Nine new thiazophthalimide derivatives were synthesized.•Thiazophthalimide compounds modulated proinflammatory cytokines IFN-y and IL-17A.•Acute toxicity studies of compound 7i in an animal model indicated low toxicity.•Compound 7i was evaluated as GABA-A receptor ligand. Epilepsy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic chemistry 2022-02, Vol.119, p.105548-105548, Article 105548
Hauptverfasser: de Oliveira, Maria Cecilia V.A., Viana, Douglas C.F., Silva, Anderson A., Pereira, Michelly C., Duarte, Filipe S., Pitta, Maira G.R., Pitta, Ivan R., Pitta, Marina G.R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Nine new thiazophthalimide derivatives were synthesized.•Thiazophthalimide compounds modulated proinflammatory cytokines IFN-y and IL-17A.•Acute toxicity studies of compound 7i in an animal model indicated low toxicity.•Compound 7i was evaluated as GABA-A receptor ligand. Epilepsy is a disease that affects millions of people around the globe and has a multifactorial cause. Inflammation is a process that can be involved in the development of seizures. Thus, the present study proposed the design and synthesis of new candidates for antiepileptic drugs that would also control the inflammatory process. Nine new derivatives of the substituted thiazophthalimide hybrid core were obtained with satisfactory purity ≥99% and yields between 27% and 87%. All compounds showed cell viability values greater than 90% in the culture of PBMC cells from healthy volunteers and, therefore, were not considered cytotoxic. These compounds modulated proinflammatory cytokines IFN-y and IL-17A and can mitigate inflammation. Acute toxicity studies of compound 7i in an animal model indicated that the compound has low toxicity and an LD50 greater than 2 g/kg in healthy adult rats. The same compound did not show positive results for anticonvulsant activity through the PTZ test. However, 7i demonstrates the interaction with the target GABA-A receptor in silico, indicating a possible activity as an agonist of that receptor. Thus, further studies are needed to investigate the anticonvulsant activity, in particular, using models in which the inflammatory process triggers epileptic seizures.
ISSN:0045-2068
1090-2120
DOI:10.1016/j.bioorg.2021.105548